<div xmlns='http://www.w3.org/1999/xhtml'><div><a name='title'> </a><h3>Colorectal Adjuvant FOLFOX (a7)</h3><div class='row'><div class='col-sm-10'><p>A drug treatment regimen for Colorectal cancer</p></div><div class='col-sm-2'>link</div></div><div class='container'><div class='row'><div class='col-sm-6'><a name='ctx'> </a><h4>Use Context</h4><div><strong>focus</strong>  Colorectal cancer http://snomed.info/sct 781382000</div><div><strong>program</strong>  FOLFOX http://snomed.info/sct FOLFOX</div><br/><a name='sf'> </a><h4>Support factors</h4><table class='table'><tr><th>Factor</th><th>Value</th></tr><tr><td>Diarrhoea risk</td><td>low</td></tr><tr><td>AntiFungal Prophylaxis</td><td>low</td></tr><tr><td>Hypersensitivity / Infusion related reaction ris</td><td>low</td></tr></table><br/><a name='rel'> </a><h4>Related artifacts</h4><table class='table'><tr><th>Type</th><th>Display</th><th>Url</th></tr><tr><td>citation</td><td>test</td><td><a href='http://www.ncbi.nlm.nih.gov/pubmed/23434' target='_blank'>http://www.ncbi.nlm.nih.gov/pubmed/23434</a></td></tr><tr><td>citation</td><td>test2</td><td><a href='http://www.ncbi.nlm.nih.gov/pubmed/34324' target='_blank'>http://www.ncbi.nlm.nih.gov/pubmed/34324</a></td></tr></table><br/></div><div class='col-sm-6'><a name='regimen'> </a><h4>Regimen details</h4><div>Cycle 1  Administration of Cabergoline and Tragacanth daily </div><div>Cycle length: 14 d Repeat:4 times</div><br/><div style='padding-left:8px'>Action 1  2mg of Cabergoline daily on days 1 and 4 by IV Infusion over 20 minutes</div><div  style='padding-left:16px'>Day#1  Specific instructions for the first administration</div><div  style='padding-left:16px'>Day#4  Specific instructions for the second administration</div><br/><div style='padding-left:8px'>Action 2  3mg of Tragacanth daily on days 2,3 and 4 by IV Infusion over 3 hours</div><div  style='padding-left:16px'>Day#2  Specific instructions for the first administration</div><div  style='padding-left:16px'>Day#3  Specific instructions for the second administration</div><div  style='padding-left:16px'>Day#4  Specific instructions for the third administration</div><br/><a name='daysum'> </a><h4>Daily Summary</h4><div>Day 1</div><div style='padding-left:8px'>2mg of Cabergoline daily on days 1 and 4 by IV Infusion over 20 minutes</div><div style='padding-left:16px'>Specific instructions for the first administration</div><div>Day 2</div><div style='padding-left:8px'>3mg of Tragacanth daily on days 2,3 and 4 by IV Infusion over 3 hours</div><div style='padding-left:16px'>Specific instructions for the first administration</div><div>Day 3</div><div style='padding-left:8px'>3mg of Tragacanth daily on days 2,3 and 4 by IV Infusion over 3 hours</div><div style='padding-left:16px'>Specific instructions for the second administration</div><div>Day 4</div><div style='padding-left:8px'>2mg of Cabergoline daily on days 1 and 4 by IV Infusion over 20 minutes</div><div style='padding-left:16px'>Specific instructions for the second administration</div><div style='padding-left:8px'>3mg of Tragacanth daily on days 2,3 and 4 by IV Infusion over 3 hours</div><div style='padding-left:16px'>Specific instructions for the third administration</div></div></div></div></div></div>